Abbott SA
71.2 FTEThe score of Abbott shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Revenue +16 % Equity 0 % Total assets 0 % Headcount (avg FTE) -18 %
Accounts of the company itself (not consolidated).
The full file covers 13 financial years; a free account shows 2. →Abbott's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | €105.6m | ||||
| Net result | €369.8m | ||||
| Equity | €2.10bn | ||||
| Cash | €1.08m | ||||
| EBITDA | €6.83m | ||||
| Total assets | €2.34bn |
Filed annual accounts
- Year ended 31 Dec 2025filed on 03 Jul 2026
- Year ended 31 Dec 2024filed on 08 Jul 2025
- Year ended 31 Dec 2023filed on 10 Jul 2024
- Year ended 31 Dec 2022filed on 05 Jul 2023
- Year ended 31 Dec 2021filed on 23 Aug 2022
Abbott's financial analysis
- Solvency90.0%sector median: 44.7%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Abbott
Abbott's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0403.044.007
- VAT number
- BE0403044007
- Peppol
- Registered · 0208:0403044007 · as of 30 Oct 2026
- Legal form
- SA
- Incorporated
- 06 Sep 1948
- Registered office
- 1300 Wavre
- Size
- Medium · 71.2 FTE
- Latest accounts
- 2025 · filed on 03 Jul 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
Abbott (SA) has been based in Wavre since 1948, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports revenue of €105.6m, a net profit of €369.8m and equity of €2.10bn. With 71.2 full-time equivalents, it is a medium-sized enterprise by headcount. Its solvency stands at 90.0%, above the median of its sector (44.7%).
Companies similar to Abbott
Companies in the same business, of comparable size and area, outside its group.
- UPSA Belgium Wholesale of pharmaceutical and medical goods Etterbeek · balance sheet €104.2m
- Abbvie Wholesale of pharmaceutical and medical goods Wavre · balance sheet €227.4m
- Viatris GX Wholesale of pharmaceutical and medical goods Hoeilaart · balance sheet €31.1m
- Depharm Wholesale of pharmaceutical and medical goods Wavre · balance sheet €26.8m
- Merck Wholesale of pharmaceutical and medical goods Hoeilaart · balance sheet €26.6m
- Linvatec Belgium Wholesale of pharmaceutical and medical goods Drogenbos · balance sheet €182.6m
- Nipro Medical Europe Wholesale of pharmaceutical and medical goods Mechelen · balance sheet €324.7m
- Perrigo Belgium Wholesale of pharmaceutical and medical goods Ghent · balance sheet €529.1m
Frequently asked questions about Abbott
What is the revenue of Abbott?
According to the 2025 annual accounts filed with the NBB, the revenue of Abbott amounts to 105,622,923 €.
What is the VAT number of Abbott?
In Belgium, the VAT number is the company number prefixed with BE: BE0403044007 for Abbott, if the company is VAT-registered. Its company number (CBE) is 0403.044.007.
Where is the registered office of Abbott?
According to the CBE register, the registered office of Abbott is in 1300 Wavre.
What is the equity of Abbott?
At the close of the 2025 financial year, the equity of Abbott amounts to 2,104,805,504 €, a solvency of 90.0% of total assets.
How many people work at Abbott?
71.2 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Abbott?
The register lists 5 active mandates at Abbott. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Abbott
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →